Vernal keratoconjunctivitis
ORPHA:70476DiseaseNot applicableChildhood
Фенотипы (HPO)23
Очень частый (80–99%)12
HP:0000481Abnormal cornea morphology
HP:0000502Abnormal conjunctiva morphology
HP:0000591Abnormal sclera morphology
HP:0000613Photophobia
HP:0001096Keratoconjunctivitis
HP:0007879Allergic conjunctivitis
HP:0009926Epiphora
HP:0011496Corneal neovascularization
HP:0011859Punctate keratitis
HP:0012393Allergy
HP:0025337Red eye
HP:0030953Conjunctival hyperemia
Частый (30–79%)6
HP:0000622Blurred vision
HP:0000643Blepharospasm
HP:0025350Giant conjunctival papillae
HP:0033841Ocular pruritus
HP:0034804Corneal foreign body sensation
HP:0100699Scarring
Периодический (5–29%)4
HP:0000498Blepharitis
HP:0000563Keratoconus
HP:0007663Reduced visual acuity
HP:0012804Corneal ulceration
Очень редкий (1–4%)1
HP:0032107Limbal stem cell deficiency
Эпидемиология7
| Тип оценки | Класс распространённости | Среднее (на 100к) | Регион | Квалификация |
|---|---|---|---|---|
| Point prevalence | >1 / 1000 | 151 | Italy | Value and class |
| Point prevalence | 1-5 / 10 000 | 45.5 | Finland | Value and class |
| Point prevalence | 1-5 / 10 000 | 49.5 | Sweden | Value and class |
| Point prevalence | 1-5 / 10 000 | 26 | Netherlands | Value and class |
| Point prevalence | 1-5 / 10 000 | 20 | France | Value and class |
| Point prevalence | 1-5 / 10 000 | 11 | Norway | Value and class |
| Point prevalence | 1-5 / 10 000 | 32 | Europe | Value and class |
Лекарства и терапия
Источник: Open Targets Platform (в реальном времени)
Клинические исследования
Источник: ClinicalTrials.gov (в реальном времени)